Attention deficit hyperactivity disorder is a disorder of brain,
formerly known as attention deficit disorder. It is one of the most
common mental disorders affecting children as well as adults.
According to an estimation by the American Psychiatric Association,
2.5% of adults and 5% of children suffer from attention deficit
hyperactivity disorder in the U.S. Among the children, the disorder
is more common in boys than in girls. Attention deficit hyperactivity
disorder is a condition where the patient has trouble in sitting
still, focusing on tasks, and paying attention. The patient acts
without thinking. This disorder can be diagnosed between the age of 6
and 12 years. The disorder is diagnosed by gathering information from
teachers, parents, and others by performing a medical evaluation
(including hearing and vision screening) and filling out checklists.
No specific cause of the disorder is known.
Report Overview @
https://www.transparencymarketresearch.com/attention-deficit-hyperactivity-disorder-market.html
Increase in the number of pre-term births of babies is a driving
factor for the attention deficit hyperactivity disorder market.
According to the University of Maryland Medical Center (UMMC),
currently, 20% of the prematurely born babies develop this disorder.
Increasing inclination of pregnant women toward toxins such as
alcohol, cigarette, and drugs leads to children born with the
attention deficit hyperactivity disorder. Complementary and
alternative therapies such as special diets, vitamins, minerals, and
herbs may restrain the attention deficit hyperactivity disorder
market during the forecast period.
The attention deficit hyperactivity disorder market can be segmented
on the basis of symptom type, treatment type, end-user, and region.
Based on symptom type, the market can be classified into impulsivity
(acting without thinking), hyperactivity (trouble in sitting still),
and inattention (trouble in focusing). Based on treatment type, the
market can be segmented into psychotherapy, medication, combination
of treatments, and others. The psychotherapy segment can be
sub-divided into family & marital therapy and behavioral therapy.
The medication segment can further be classified into stimulants and
non-stimulants. The medication segment is anticipated to hold a large
market share during the forecast period, due to technological
advancements and increasing R&D activities. Psychotherapy and
combination of treatments segments are expected to expand at a
moderate rate during the forecast period, owing to increasing
awareness about attention deficit hyperactivity disorder among the
people and technological advancements. Based on end user, the market
can be segmented into pediatric clinics, psychological centers,
hospitals and others.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32177
Geographically, the global attention deficit hyperactivity disorder
market can be divided into Asia Pacific, Latin America, Middle East &
Africa, North America, and Europe. North America is expected to hold
a leading market share from 2017 to 2025, owing to high usage of
cigarettes, alcohol, and drugs during pregnancy in the region.
According to the American Psychiatric Association, in the U.S.,
approximately 1 in 20 children is affected by attention deficit
hyperactivity disorder. In terms of market share, Europe is projected
to follow North America during the forecast period, due to high
prevalence of attention deficit hyperactivity disorder in the region.
For instance, the prevalence of attention deficit hyperactivity
disorder is high in Ukraine, due to psychosocial dislocation and
environmental adversity associated with the Chernobyl disaster. The
market in Asia Pacific, Middle East & Africa, and Latin America
is anticipated to expand at a significant rate during the forecast
period, due to growing population of baby boomers and high rate of
nutritional deficiencies and imbalances among children in developing
countries in these regions.
Key players operating in the global attention deficit hyperactivity
disorder market are Janssen Global Services, LLC, Cingulate
Therapeutics, LLC, Shire, Eli Lilly and Company, Purdue Pharma L.P.,
GlaxoSmithKline plc, and Novartis AG.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=32177<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment